CRISPR allows scientists to make precision edits to any DNA, whether bacterial or human.
Scientists discovered the technique when studying a bacteria's immune system, which they gave the acronym CRISPR. It stands for clustered regularly interspaced short palindromic repeats.
UK-listed Horizon’s team-up with Mammoth is an interesting one given its co-founder is Jennifer Doudna, a world-renowned leader in what known as the CRISPR revolution.
Mammoth received a lot of press around its Series A financing last year that brought in Apple CEO Tim Cook and Jeff Huber, former CEO of early cancer screening company Grail.